ArticleHemaSphere2018
Maintenance Therapy With Interleukin-2 for Childhood AML: Results of ELAM02 Phase III Randomized Trial.
Arnaud Petit et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
15 papers cite it
this papercites it
ArticleHemaSphere2018
Arnaud Petit et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.